✦ LIBER ✦

Oral zinc sulfate treatment for viral warts: An open-label study

✍ Scribed by Je-Ho MUN; Su-Han KIM; Do-Sang JUNG; Hyun-Chang KO; Byung-Soo KIM; Kyung-Sool KWON; Moon-Bum KIM

Book ID: 108577951
Publisher: John Wiley and Sons
Year: 2010
Tongue: French
Weight: 200 KB
Volume: 38
Category: Article
ISSN: 0385-2407
DOI: 10.1111/j.1346-8138.2010.01056.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral zinc sulfate for unresponsive cutan

Oral zinc sulfate for unresponsive cutaneous viral warts: too good to be true? A double-blind, randomized, placebo-controlled trial

✍ D. R. López-García; M. Gómez-Flores; A. Y. Arce-Mendoza; A. De La Fuente-García 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 589 KB

Medical mushrooms used for biochemical f

Medical mushrooms used for biochemical failure after radical treatment for prostate cancer: An open-label study

✍ Koji Yoshimura; Toshiyuki Kamoto; Osamu Ogawa; Shigeyuki Matsui; Norihiko Tsuchi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

Combination of mood stabilizers with que

Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: an open label study

✍ Won-Myong Bahk; Bo-Hyun Yoon; Kyoung-Uk Lee; Jeong-Ho Chae 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

## Abstract ## Objectives The atypical antipsychotics are being increasingly used to control acute manic episodes, and data are emerging to support their mood‐stabilizing and antidepressant properties. This study investigated the short‐term efficacy of quetiapine as an add‐on therapy in the treatm

Long-Term, Open-Label Safety Study of Or

Long-Term, Open-Label Safety Study of Oral Almotriptan 12.5 mg for the Acute Treatment of Migraine in Adolescents

✍ Frank Berenson; Elza Vasconcellos; Ann Pakalnis; Lian Mao; David M. Biondi; Robe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

An open-label study of escitalopram (Lex

An open-label study of escitalopram (Lexapro®) for the treatment of ‘Depression of Alzheimer's disease’ (dAD)

✍ V. Rao; J. R. Spiro; P. B. Rosenberg; H. B. Lee; A. Rosenblatt; C. G. Lyketsos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

## Abstract ## Background Depression is a frequent neuropsychiatric complication of Alzheimer's Disease. ## Methods This study investigated the safety and effectiveness of escitalopram (LEXAPRO) for depression in AD (dAD) as defined by the NIMH consensus criteria in an 8‐week, open‐label treatme

Extracorporeal photopheresis for the tre

Extracorporeal photopheresis for the treatment of refractory Crohn's disease: Results of an open-label pilot study

✍ Maria T. Abreu; Christian von Tirpitz; Robert Hardi; Martin Kaatz; Gert Van Assc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 2 views

## Background: Extracorporeal photopheresis (ecp) is effective in immune-mediated disorders. a prospective, uncontrolled pilot study was conducted to evaluate the safety and efficacy of ecp in patients with active crohn's disease (cd) who were refractory to or intolerant of immunosuppressants and/o